-
2
-
-
4444288490
-
On improved estimation of parameters subject to order restrictions
-
Dunbar S, Conaway M, Peddada S. On improved estimation of parameters subject to order restrictions. Stat Appl. 2001 ; 3: 121-28
-
(2001)
Stat Appl
, vol.3
, pp. 121-28
-
-
Dunbar, S.1
Conaway, M.2
Peddada, S.3
-
3
-
-
21344486796
-
Confidence interval estimation subject to order restrictions
-
Hwang J, Peddada S. Confidence interval estimation subject to order restrictions. Ann Stat. 1994 ; 22: 67-93
-
(1994)
Ann Stat
, vol.22
, pp. 67-93
-
-
Hwang, J.1
Peddada, S.2
-
4
-
-
0025148278
-
Continual reassessment method: A practical design for phase 1 clinical trials in cancer
-
DOI 10.2307/2531628
-
O'Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for Phase I clinical trials in cancer. Biometrics. 1990 ; 46: 33-48 (Pubitemid 20245604)
-
(1990)
Biometrics
, vol.46
, Issue.1
, pp. 33-48
-
-
O'Quigley, J.1
Pepe, M.2
Fisher, L.3
-
5
-
-
0029938415
-
Continual reassessment method: A likelihood approach
-
O'Quigley J, Shen LZ. Continual reassessment method: a likelihood approach. Biometrics. 1996 ; 52: 163-74
-
(1996)
Biometrics
, vol.52
, pp. 163-74
-
-
O'Quigley, J.1
Shen, L.Z.2
-
6
-
-
0031920799
-
Cancer phase I clinical trials: Efficient dose escalation with overdose control
-
DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0. CO;2-9
-
Babb J, Rogatko A, Zacks S. Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat Med. 1998 ; 17: 1103-20 (Pubitemid 28221028)
-
(1998)
Statistics in Medicine
, vol.17
, Issue.10
, pp. 1103-1120
-
-
Babb, J.1
Rogatko, A.2
Zacks, S.3
-
7
-
-
0033618612
-
Continual reassessment methods in phase I trials of the combination of two drugs in oncology
-
DOI 10.1002/(SICI)1097-0258(19990730)18:14<1849::AID-SIM222>3.0. CO;2-I
-
Kramar A, Lebecq A, Candalh E. Continual reassessment methods in phase I trials of the combination of two agents in oncology. Stat Med. 1999 ; 18: 1849-64 (Pubitemid 29364055)
-
(1999)
Statistics in Medicine
, vol.18
, Issue.14
, pp. 1849-1864
-
-
Kramar, A.1
Lebecq, A.2
Candalh, E.3
-
8
-
-
59349088647
-
A comprehensive comparison of the continual reassessment method to the standard 3+3 dose escalation scheme in Phase i dose-finding studies
-
Iasonos A, Wilton A, Riedel E, et al. A comprehensive comparison of the continual reassessment method to the standard 3+3 dose escalation scheme in Phase I dose-finding studies. Clin Trials. 2008 ; 5: 465-77
-
(2008)
Clin Trials
, vol.5
, pp. 465-77
-
-
Iasonos, A.1
Wilton, A.2
Riedel, E.3
-
9
-
-
15044354311
-
Two-dimensional dose finding in discrete dose space
-
DOI 10.1111/j.0006-341X.2005.030540.x
-
Wang K, Ivanova A. Two-dimensional dose finding in discrete dose space. Biometrics. 2005 ; 61: 217-22 (Pubitemid 40380982)
-
(2005)
Biometrics
, vol.61
, Issue.1
, pp. 217-222
-
-
Wang, K.1
Ivanova, A.2
-
10
-
-
63849316345
-
Bayesian dose finding for drug combinations by copula regression
-
Yin G, Yuan Y. Bayesian dose finding for drug combinations by copula regression. J Roy Stat Soc C Appl. 2009 ; 581: 211-24
-
(2009)
J Roy Stat Soc C Appl
, vol.581
, pp. 211-24
-
-
Yin, G.1
Yuan, Y.2
-
11
-
-
70349251729
-
A latent contingency table approach to dose-finding for combinations of two agents
-
Yin G, Yuan Y. A latent contingency table approach to dose-finding for combinations of two agents. Biometrics. 2009 ; 65: 866-75
-
(2009)
Biometrics
, vol.65
, pp. 866-75
-
-
Yin, G.1
Yuan, Y.2
-
13
-
-
4444244983
-
Designs for single- or multiple-agent phase I trials
-
DOI 10.1111/j.0006-341X.2004.00215.x
-
Conaway M, Dunbar S, Peddada S. Designs for single- or multiple-agent phase I trials. Biometrics. 2004 ; 60: 661-69 (Pubitemid 39181110)
-
(2004)
Biometrics
, vol.60
, Issue.3
, pp. 661-669
-
-
Conaway, M.R.1
Dunbar, S.2
Peddada, S.D.3
-
14
-
-
1142304984
-
Non-parametric optimal design in dose finding studies
-
DOI 10.1093/biostatistics/3.1.51
-
O'Quigley J, Paoletti X, Maccario J. Non-parametric optimal design in dose-finding studies. Biostatistics. 2002 ; 3: 51-56 (Pubitemid 34374242)
-
(2002)
Biostatistics Oxford
, vol.3
, Issue.1
, pp. 51-56
-
-
O Quigley, J.1
Paoletti, X.2
Maccario, J.3
-
15
-
-
0034908645
-
Phase I clinical trial of weekly combined topotecan and irinotecan
-
DOI 10.1097/00000421-200108000-00003
-
Lokich J. Phase I clinical trial of weekly combined topotecan and irinotecan. Am J Clin Oncol. 2001 ; 24: 336-40 (Pubitemid 32730723)
-
(2001)
American Journal of Clinical Oncology: Cancer Clinical Trials
, vol.24
, Issue.4
, pp. 336-340
-
-
Lokich, J.1
-
16
-
-
67649321803
-
Model calibration in the continual reassessment method
-
Lee SM, Cheung YK. Model calibration in the continual reassessment method. Clin Trials. 2009 ; 6: 227-38
-
(2009)
Clin Trials
, vol.6
, pp. 227-38
-
-
Lee, S.M.1
Cheung, Y.K.2
-
17
-
-
0036712359
-
A simple technique to evaluate model sensitivity in the continual reassessment method
-
Cheung YK, Chappell R. A simple technique to evaluate model sensitivity in the continual reassessment method. Biometrics. 2002 ; 58: 671-74 (Pubitemid 35001486)
-
(2002)
Biometrics
, vol.58
, Issue.3
, pp. 671-674
-
-
Cheung, Y.K.1
Chappell, R.2
|